• ALGAE
• /
• v.19 no.4
• /
• pp.329-337
• /
• 2004

Monthly variations of phytoplankton communities were conducted to the investigation at five stations in mid and lower parts of the Nakdong River from December 1995 to November 1996. The phytoplankton communities were identified a total 456taxa which were composed of 136 genera, 427 species, 27 varieties and 2 forma. The standing crops of phytoplankton communities ranged from 2.7 to 52.8 (${\times}$10³)cells·ml$^{-1}$ during the investigation periods. Bacillariophyceae was the dominant classes at all stations. The dominant species were 7taxa and the standing crops of these ranged from 18.3 to 95.1% of the standing crops of phytoplankton communities. The dominant species in the mid parts (st. 1, 2) of this river system were benthic species such as Navicula gregaria, N. viridula var. rostellata and Nitzschia palea, however it was planktonic species (Stephan discus hantzschii, Golenkinia radiata) and meroplanktonic species (Aulacoseira ambigua, A. granulata) in the lower parts (st. 3, 4, 5). The seasonal variations of the dominant species in the lower parts were appeared to the planktonic species (S. hantzschii) from winter to spring, and were the meroplanktonic species (A. ambigua and A. granulata) in from summer to fall. The lower parts of the Nakdong river were entropic states because the dominant species were composed A. ambigua, A. granulate and S. hantzschii which were indicators of entropic water quality. The interrelationships between total standing crops and environmental factors(water temperature, pH, NH$_4$, NO$_2$, NO$_3$ and PO$_4$) were low positive or negative coefficients. S. hantzschii had low positive or negative relations with water temperature, NH$_4$, NO$_2$, NO$_3$ and PO$_4$. As the result, the variations of standing crops of phytoplankton were not caused by a single factor but controlled by the complex factors.

• Women's Health Nursing
• /
• v.10 no.2
• /
• pp.138-143
• /
• 2004

Purpose: The purpose of this study was to test the effect of an integrated health promotion program in middle-aged women. Method: The research design was a quasi experimental, one-group pretest-posttest design. Data was collected from July 1st to August 31st, 2003. One group consisted of 30 subjects. The instruments used for the study were the Self Efficacy Scale and the Health Promotion Behavior Scale developed by Park(1995), Subjective health status developed Speake(1989) and menopause-related symptoms developed by Park(1995). The data was analyzed using the SPSS WIN 10.0 program. In order to compare the effects of the pre-post synthesized health promotion program, the ed t-test was employed. Result: There was not a significant increase in subjective health status after the integrated health promotion program, nor was there a significant decrease in menopause-related symptoms after the synthesized health promotion program. There was a significant increase in self efficacy after the integrated health promotion program(p=.029), and there was also a significant increase in health promotion behavior after the integrated health promotion program(p=.006). Conclusions: Through an 8 week education program for health promotion, self efficacy and health promotion behavior were effectively changed in middle-aged women.

• Journal of Microbiology and Biotechnology
• /
• v.23 no.5
• /
• pp.699-706
• /
• 2013

We have previously reported that N-acetylcysteine (NAC) not only delayed apoptosis but also enhanced the production of recombinant erythropoietin (EPO) in Chinese hamster ovary (CHO) cell culture. To investigate the production enhancement mechanism, the effects of similar thiol-reducing agents were studied. Intriguingly, all mild reducing agents examined including mercaptoethanesulfonic acid (MESNA), thiolactic acid (TLA), and thioglycolate (TG) were shown to block apoptosis and increase EPO production. A pulse-chase study of EPO secretion revealed that all four thiol-reducing agents increased the EPO secretion rate; among them TLA showed the highest rate. In terms of product quality, the sialic acid content of the glycoprotein is one of the most important factors. It was reported that a number of glycoproteins produced by CHO cells often have incomplete sialylation, particularly under high-producing conditions. Human ${\alpha}2,3$-sialyltransferase (${\alpha}2,3$-ST) was introduced into EPO-producing CHO cells in order to compensate for the reduced sialylation during supplementation with NAC. When ${\alpha}2,3$-ST was expressed in the presence of NAC, reduced sialylation was restored and an even more sialylated EPO was produced. Thus, our study is significant in that it offers increased EPO production while still allowing the prevention of decreased sialylation of EPO.

• Korean Journal of Fisheries and Aquatic Sciences
• /
• v.46 no.4
• /
• pp.351-358
• /
• 2013

A protease inhibitor from fish eggs was fractionated using chromatographic methods. The fractionation efficiency was evaluated in terms of specific inhibitory activity (SIA, U/mg), purity (fold), total inhibitory activity (TIA, U), and recovery (%). The protease inhibitor (PI) from egg extracts of skipjack tuna (ST Katsuwonus pelamis), yellowfin tuna (YT Thunnus albacares) and Alaska pollock (AP Theragra chalcogramma) was fractionated using Sephadex G-50 gel filtration and DEAE-Sepharose CL-6B anion exchange chromatography based on protein size exclusion and net charge, respectively. Fractions exhibiting strong inhibitory activity were contained in the 30-50 kDa fraction on gel filtration and in the range of 0.4-0.7 M NaCl gradient fraction on anion exchange chromatography. The respective TIA and percent recovery of the fraction obtained with gel filtration toward trypsin and $N{\alpha}$-benzoyl-L-arginine-p-nitroanilide (BAPNA) were 2,758.7 U and 29.6% for ST, 1,005.5 U and 25.6% for YT, and 1,267.5 U and 26.0% for AP. Gel filtration chromatography was more effective at fractionating PI than using ion exchange chromatography. These results suggest that fish eggs act as serine protease inhibitors and might be useful for protease inhibition in foodstuffs.

• Polymer(Korea)
• /
• v.34 no.1
• /
• pp.38-44
• /
• 2010

Core-shell particles of inorganic/organic pair were synthesized from $CaCO_3$ absorbed sodium dodecyl benzene sulfonate(SDBS) surfactant. Shell components were synthesized by sequential emulsion polymerization. Various monomers were used as shell components such as methyl methacrylate(MMA), ethyl acrylate(EA), butyl acrylate(BA), and styrene(St). Ammonium persulfate(APS) was used as an initiator and 2-ethylhexyl acylate(2-EHA) was used as a functional monomer, In the $CaCO_3$/organic core-shell particle polymerization, $CaCO_3$ absorbed surfactant SDBS of 0.5 wt% was prepared first and then core $CaCO_3$ was encapsulated by emulsion polymerization. 0.1 wt% of APS was added sequentially to minimize the formation of new monomer particle during shell polymerization. The structure of inorganic/organic core-shell particles were characterized by measuring the decomposition degree of $CaCO_3$ using HCl solution, thermogravimetric analyzer, scanning electron microscope, and transmission electron microscope.

• Journal of Acupuncture Research
• /
• v.20 no.2
• /
• pp.112-122
• /
• 2003

연구 배경 및 목적 : 봉독은 항염증 등의 효과를 가지고 있다고 알려져 있지만 세포 증식과 관련된 봉독의 효과에 대한 고찰을 위해 본 연구(硏究)에서는, 봉독(蜂毒) 약침(藥鍼) 자극(刺戟)이 아세트산 유발(誘發) 통각(痛覺) 과민증(過敏症)을 가진 쥐의 치상회(齒狀回)에서의 세포(細胞) 증식(增植)과 COX2 발현(發現)에 미치는 영향(影響)에 대해 알아보고자 하였다. 실험방법 : 대조군, 아세트산 처치군, 아세트산 0.1mg/kg 봉독 처치군, 아세트산 1mg/kg 봉독처치군(n=5 in each group)의 네 군으로 나누고 해당 군에 일벌 봉독(蜂毒)(Sigma Chemical Co., St. Louis, MO, USA)을 양측 족삼리 경혈(ST36)에 주입시키고 30분 후 아세트산(100% acetic acid 1% 용액의 0.5ml)을 복강내로 주입하여 복부 긴장 회수를 세었으며, BrdU 양성, COX 2 양성 세포수를 면역 화학 조직법을 수행하여 세어 보았다. 결과 : 아세트산 처치군에서는 대조군에 비해 5 bromo 2' deoxyuridine 양성 세포의 수는 감소(減少)되며, 치상회(齒狀回)에서의 COX 2의 발현(發現)은 증강(增强)되는 것으로 보여졌다. 봉독(蜂毒) 주입(注入)은 아세트산 유발(誘發) 복부(腹部) 긴장(緊張) 횟수와 치상회(齒狀回)에서의 COX2 발현(發現)을 억제(抑制)하여, 치상회(齒狀回)에서의 세포(細胞) 증식(增植)을 증가(增加)시켰다. 결론 : 이번 결과(結果)에서 보면, 치상회(齒狀回)에서의 COX 2의 발현(發現)은 세포(細胞) 증식(增植) 억제(抑制)와 관련(關聯)되며 봉독(蜂毒)은 COX 2 발현(發現) 억제(抑制)를 통해 치상회(齒狀回)에서의 새로운 세포(細胞) 형성(形成)을 증가(增加)시킨다는 것을 알 수 있다.

• The korean journal of orthodontics
• /
• v.42 no.4
• /
• pp.207-217
• /
• 2012

Objective: This study aimed to evaluate the effect of an intentionally created socket on bone remodeling with orthodontic tooth movement in rabbits. Methods: Eighteen male rabbits weighing 3.8 - 4.25 kg were used. An 8-mm deep and 2-mm wide socket was drilled in the bone 1 mm mesial to the right mandibular first premolar. The left first premolar was extracted to serve as an extraction socket. A traction force of 100 cN was applied to the right first premolar and left second premolar. Sections were obtained at the middle third of the moving tooth for both the drilled and extraction sockets and evaluated with hematoxylin and eosin staining and immunohistochemical analyses. The amount of tooth movement and tartrate-resistant acid phosphatase (TRAP)-positive cell count were compared between the 2 groups using the Mann-Whitney U test. Results: At week 2, the distance of tooth movement was significantly higher in the intentional socket group (p < 0.05) than in the extraction socket group. The number of TRAP-positive cells decreased in week 2 but increased in week 3 (p < 0.05). However, there were no significant differences between the groups. Furthermore, results of transforming growth factor (TGF)-${\beta}$ staining revealed no significant differences. Conclusions: The intentional socket group showed greater distance of tooth movement than did the extraction socket group at week 2. Osteoclast counts and results of immunohistochemical analyses suggested elevated bone remodeling in both the groups. Thus, osteotomy may be an effective modality for enhancing tooth movement in orthodontic treatment.

• Journal of Korean Traditional Oncology
• /
• v.16 no.1
• /
• pp.33-39
• /
• 2011

Objective : To investigate the anti-metastasis and preventing relapses of HangAm-Plus (HAP) on pancreatic cancer patient. Methods : A 49 year old male patient diagnosed with pancreatic cancer (T3N0M0) was admitted to EWCC (East-West Cancer Center) on Jul. 21st 2008. He had operated pylorus preserving pancreatoduodenectomy (PPPD) and came to the anti-metastasis and preventing relapses on pancreatic cancer patient. The patient was treated with HangAm-Plus (HAP) (3,000 mg/day) for the period of 33 months from Jul. 21st, 2008 to Apr. 7th, 2011. Tumor markers (CEA and CA19-9) were used to evaluate the disease progression of the patient. Positron Emission Tomography (PET) and Computed Tomography (CT) were also followed up. Results : HAP treatment was well tolerated by the patient. Patient has shown 33 months of disease free survival until now. Conclusion : This case study supports HAP's potential efficacy in the anti-metastasis and preventing relapses of pancreatic cancer patient.

• Journal of Korean Society of Occupational and Environmental Hygiene
• /
• v.3 no.2
• /
• pp.194-203
• /
• 1993

Quality Control programs for industrial hygiene laboratory have successfully been operated since the 1st round was initiated in April 1992. Three rounds have been completed. Overall analytical performance of participants was improved through a subsquent round. The first round had a large variation among analytical results of all participants, 26.34%~504.22% of coefficient of variation. But the variation of analytical performance in the 2nd and 3rd rounds decreased to 40.42%~52.55% and 10.74%~20.98%, respectively. The difference of analytical performance among participants was decreased by operation of subsquent round. By distribution of Running Performance Index (RPI), over 50% of participants belongs to Category 3 in the first round. The average percentage of participants assigned to Category 3 in the 2nd and 3rd round was decreased to 37.2%. A definite analytical performance improvement of participants seems to be obtained. "A" and "B" group have more participants assigned to Category 3 than those of "C" group through the distribution of RPI by group divided to similar participant. By the distribution of RPI all participants, the percent of participant being over 200 RPI in the 1st round was 43%~52%, but decreased to 9%~29% and 9%~27%, in the 2nd and 3rd round, respectively. These results mentioned above indicate that the analytical performance of all participants have been improved by subsquent Quality Control Program although newcomers joined and a few participants droped out. But, there are some participants with poor analytical performance. Industrial Health Research Institute (IHRI) will offer service such as education, communication and visitation to them, and improve quality of their analytical performance in the future.

• Korean Journal of Clinical Pharmacy
• /
• v.30 no.3
• /
• pp.196-205
• /
• 2020

Background: The indication of denosumab for osteoporosis was expanded from second-line to first-line therapy in 2019. The aim of this study was to evaluate the efficacy of denosumab as both first- and second-line therapy in postmenopausal women with osteoporosis and osteopenia with risk factors by using the Fracture Risk Assessment Tool (FRAX). Methods: We conducted a medication use evaluation of denosumab in 98 patients who had been treated three or more times for osteoporosis or osteopenia at Chungnam National University Hospital from July 1^st, 2017 to January 31^st, 2020. Risk factors were identified using quantitative N-gram analyses of FRAX estimations. Patient information, including menopause status and results of bone mineral density tests (T-score), was obtained from electronic medical records. Results: Age, body mass index (BMI), prior medication use, and T-score were identified as risk factors and were included as variables in the evaluation of denosumab use. Since no significant differences were detected between groups, denosumab is likely effective regardless of age or BMI. In addition, no significant difference was detected in T-scores following denosumab treatment, between groups who took bisphosphonates and selective estrogen receptor modulators (SERMs) with denosumab as first-line therapy for postmenopausal osteoporosis. Denosumab may, therefore, be effective as second-line therapy. Conclusion: Efficacy of denosumab was evaluated in postmenopausal women with osteoporosis. Denosumab may be used as first- and second-line therapy regardless of age, BMI, and prior use of bisphosphonates and SERMs.